Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flavocoxid vs Naproxen in Knee Osteoarthritis
NCT00790985Phase 3Completed
- Sponsor
- Primus Pharmaceuticals
- Start
- Jan 2008
- Primary completion
- Aug 2008
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of flavocoxid in osteoarthritis (OA) (2 arms), sponsored by Primus Pharmaceuticals. Primary endpoint: Western Ontario and McMaster Universities Arthritis Composite Score at 12 weeks. Started Jan 2008; status: completed.
02
Drugs
flavocoxid
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT00790985.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00790985.